This Full Spectrum CBD Infused
Product Line contains 25mg per Serving (“Bite”) / 600mg per Jar
(“Unit”)
NEW YORK, NY -- March 5, 2021 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating, diversified
life sciences company, with a proprietary line of CBD & CBG
infused Supplement chewing gums (Flavors: Pomegranate, Blood
Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional
product offerings, as well as an ongoing Pharmaceutical Development
initiative, today announced that it has selected First Foods Group,
Inc. (OTCQB: FIFG) to manufacture its new, full spectrum CBD
infused product line. Through this Manufacturing partnership,
First Foods Group, Inc. (“First Foods”) and Tauriga Sciences, Inc.
(“Tauriga”) have created a variety of three chocolate-based
products – that leverage the capabilities of South East Edibles
(First Foods’ flagship brand). The products are comprised of
full spectrum CBD infused, chocolate-based candies, that are:
Kosher Certified (Orthodox Union), Vegan, Dairy-Free, All Natural,
Artisan Crafted.
Tauriga’s full spectrum CBD infused product line consists of the
following three offerings:
- White Chocolate with Melatonin + Lavender + Chamomile (Sugar
Free) . . . 600mg Full Spectrum CBD per Unit
DIABETIC FRIENDLY
- White Chocolate with Turmeric + Ginger + Lemon +
Black Pepper (Sugar Free) . . . 600mg Full Spectrum CBD per
Unit
DIABETIC FRIENDLY
- White Chocolate with Coconut Milk (Sugar Based)
. . . 600mg Full Spectrum CBD per Unit
Tauriga’s CEO Seth M. Shaw expressed, “For the past several
months, our management team has been searching for a Manufacturing
partner to create an innovative, high quality, full spectrum CBD
product line. We are proud to have selected First Foods
Group, Inc. with their impressive team and innovation-based
approach. Additionally, First Foods is the manufacturer and
controls the entire process – and most importantly – the quality
assurance protocols. We are continuing to expand our product
lines and offerings as we build our customer base and focus on long
term growth – with respect to our retail business.”
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and
initiatives. The company manufactures and distributes
several proprietary retail products and product lines, mainly
focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles
market segment. The main product line, branded as
Tauri-Gum™, consists of a proprietary supplement chewing gum that
is Kosher certified, Halal certified, and Vegan Formulated (CBD
Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG
Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) &
(Vitamin C + Zinc “Immune Booster” Flavor: Pear
Bellini). The Company’s commercialization strategy
consists of a broad array of retail customers, distributors, and a
fast-growing E-Commerce business segment (E-Commerce
website: www.taurigum.com). Please visit our corporate
website, for additional information, as well as inquiries, at
http://www.tauriga.com.
Complementary to the Company’s retail business, is its ongoing
Pharmaceutical Development initiative. This relates to the
development of a proposed Pharmaceutical grade version of
Tauri-Gum™, for nausea regulation (specifically designed for the
following indication: Patients Subjected to Ongoing Chemotherapy
Treatment). On March 18, 2020, the Company announced that it had
filed a provisional U.S. patent application covering its
pharmaceutical grade version of Tauri-Gum™. The Patent, filed
with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS
OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18,
2020 the Company disclosed that it had entered into a Master
Services Agreement with CSTI to lead the Company's clinical
development efforts.
The Company is headquartered in Wappingers Falls, New
York. In addition, the Company operates a full time
E-Commerce fulfillment center located in LaGrangeville, New
York.
About First Foods Group, Inc.
First Foods Group, Inc. (OTCQB: FIFG) is a US holding company
specializing in the sale of a variety of Cannabidiol (CBD) based
products through its subsidiary, Southeast Edibles, based in the
USA. Its state-of-the-art facility is based in Fort Lauderdale, FL.
Products include infused premium specialty chocolate edibles all
made in the USA. First Foods seeks synergistic value through
creating its own new concepts, both through proprietary
development, mergers, acquisitions and licensing arrangements in
the CBD and health and wellness space. Management is committed to
an integrated approach using the highest quality hemp solutions and
highest purity standards in the industry. First Foods Group Inc,
also provides management services and funding options for emerging
supplement brands and menu concepts.
To learn more about First Foods, please visit our
website: https://www.firstfoodsgroup.com
To learn more about our Southeast Edibles product line, please
visit: https://www.southeastedibles.com
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due to
known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other periodic filings made from time to time with the
Securities and Exchange Commission. Such forward-looking statements
are made only as of the date of this release, and Tauriga assumes
no obligation to update forward-looking statements to reflect
subsequent events or circumstances. You should not place undue
reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com